Achillion Pharmaceuticals, Inc. Reports Second Quarter and Six Month 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW HAVEN, Conn., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and six months ended June 30, 2013 and provided an update on the Company's portfolio of clinical stage compounds being developed for the treatment of the hepatitis C virus (HCV).
Help employers find you! Check out all the jobs and post your resume.
NEW HAVEN, Conn., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three and six months ended June 30, 2013 and provided an update on the Company's portfolio of clinical stage compounds being developed for the treatment of the hepatitis C virus (HCV).
Help employers find you! Check out all the jobs and post your resume.